Professional Summary

Professional Overview

Jennifer Iaci is a seasoned biopharmaceutical executive with over 25 years of experience in research, operations, and medical affairs. As the Vice President at Cognition Therapeutics, Inc., she leverages her deep scientific expertise and strategic leadership to drive the company's research and development efforts, with a focus on advancing novel therapeutic solutions for neurological and cognitive disorders.

Experience Summary

Current Role

As Vice President at Cognition Therapeutics, Inc., Jennifer is responsible for overseeing the company's R&D operations, including project management, scientific communications, and medical affairs. She plays a pivotal role in aligning the organization's strategic vision with its day-to-day activities, ensuring efficient and effective execution of key research initiatives. Under her leadership, Cognition Therapeutics has made significant strides in progressing its clinical pipeline and establishing valuable industry partnerships.

Career Progression

Prior to her current role, Jennifer served as the Executive Director of R&D Operations at Cognition Therapeutics, where she streamlined processes and implemented best practices to enhance the company's research capabilities. She has also held positions as the Senior Director of Program Management at Ovid Therapeutics and the Vice President of Science and Medical Operations at Cognition Therapeutics, demonstrating her versatility and ability to drive progress across diverse functional areas.

Earlier in her career, Jennifer was the Director of Scientific Communications and Medical Affairs at Acorda Therapeutics, Inc., where she played a crucial role in elevating the company's scientific profile and fostering effective collaborations with key opinion leaders. She also served as the Director of Research and Collaborations at Acorda Therapeutics, leveraging her deep scientific understanding to advance the organization's research agenda.

Academic Background

Jennifer holds a Bachelor of Science degree in Biology from the University of Delaware, where she excelled academically and developed a strong foundation in the life sciences.

Areas of Expertise

Jennifer's areas of expertise include project management, scientific communications, medical affairs, and R&D operations. She has a proven track record of driving strategic initiatives, fostering cross-functional collaboration, and leveraging her scientific expertise to navigate complex research and development challenges. Jennifer's leadership skills and ability to translate scientific insights into actionable business strategies have been instrumental in her success.

Professional Impact

Throughout her career, Jennifer has played a pivotal role in advancing the development of innovative therapies for neurological and cognitive disorders. She has contributed to the successful progression of multiple clinical programs, forged valuable industry partnerships, and effectively communicated scientific findings to diverse stakeholders. Jennifer's commitment to excellence and her ability to drive tangible results have made her a highly respected leader in the biopharmaceutical industry.

Conclusion

With her extensive experience, strong scientific acumen, and strategic leadership capabilities, Jennifer Iaci is poised to continue making significant contributions to the advancement of Cognition Therapeutics' research and development efforts. Her proven track record of driving progress and her unwavering dedication to improving patient outcomes position her as a valuable asset to the organization and the broader biopharmaceutical industry.